Emtricitabine/TDF 200 mg/1
Emtricitabine/TDF · TABLET, FILM COATED · Direct_Rx
Emtricitabine/tenofovir disoproxil fumarate is a combination medication used to treat human immunodeficiency virus (HIV) infection. This oral tablet combines two nucleoside reverse transcriptase inhibitors, which work by blocking the virus's ability to replicate in the body.
Key Facts
- Brand Name
- Emtricitabine/TDF
- Generic Name
- Emtricitabine/TDF
- NDC Code (Product)
72189-403- Manufacturer
- Direct_Rx
- Strength
- 200 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- ANDA090513
- Drug Class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 12/05/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is Emtricitabine/TDF used for?
Emtricitabine/tenofovir disoproxil fumarate is a combination medication used to treat human immunodeficiency virus (HIV) infection. This oral tablet combines two nucleoside reverse transcriptase inhibitors, which work by blocking the virus's ability to replicate in the body.
Is Emtricitabine/TDF a controlled substance?
Emtricitabine/TDF is not classified as a controlled substance by the DEA.
What is the generic name for Emtricitabine/TDF?
The generic name for Emtricitabine/TDF is Emtricitabine/TDF. There are no other listed brand versions of Emtricitabine/TDF.
What is the NDC code for Emtricitabine/TDF 200 mg/1?
The NDC (National Drug Code) for Emtricitabine/TDF 200 mg/1 is 72189-403, listed by Direct_Rx.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)